NCT01949883View on ClinicalTrials.gov

A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 5, 2013

Primary Completion Date

December 20, 2017

Study Completion Date

December 20, 2017

Conditions
Lymphoma
Interventions
DRUG

CPI-0610

Sponsors
All Listed Sponsors
collaborator

The Leukemia and Lymphoma Society

OTHER

lead

Constellation Pharmaceuticals

INDUSTRY

NCT01949883 - A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma | Biotech Hunter | Biotech Hunter